SRSF2 and myeloid neoplasm: In contrast, SRSF2 mutations are not restricted to any specific myeloid neoplasm but are associated with altered myeloid differentiation, disrupting other genes and thereby causing distinctive clinical manifestations of myelofibrosis, monocytosis, and blast phase [78].